COLD-FX® Class Action Appeal Dismissed by the BC Court of Appeal
Toronto, Ontario – May 2nd, 2018 –The British Columbia (B.C.) Court of Appeal has dismissed a proposed class action proceeding related to the effectiveness of COLD-FX®. Valeant Canada, manufacturer of COLD-FX®, is pleased to see this matter closed.
At Valeant Canada, we are dedicated to improving people’s lives with our healthcare products. COLD-FX® has been thoroughly evaluated, researched and clinically assessed and has been proven to help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.[i] More than $20 million has been invested over more than a decade in clinical research and development of COLD-FX®. For eleven years, COLD-FX® has been the #1 Pharmacist and Doctor Recommended Natural Cold Remedy brand in Canada.[ii]
COLD-FX® is produced by Valeant Canada, a subsidiary of Valeant Pharmaceuticals International, Inc., a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about COLD-FX® can be found at www.cold-fx.ca. More information about Valeant Canada can be found at www.valeantcanada.com.
For additional information, please contact:
Argyle Public Relationships
416-968-7311 ext. 242
[i] Health Canada “COLD-FX® Monograph”:https://health-products.canada.ca/lnhpd-bdpsnh/info.do?licence=80002849 . Accessed on July 6, 2016
[ii] Canadian Healthcare Network. “2015 Counselling and Recommendations Survey.” Retrieved from: https://www.canadianhealthcarenetwork.ca/otc2015/pharmacists-physicians. Accessed on February 8, 2016.